Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · IEX Real-Time Price · USD
19.98
-0.06 (-0.30%)
At close: Jul 2, 2024, 4:00 PM
19.58
-0.40 (-2.00%)
After-hours: Jul 2, 2024, 7:08 PM EDT
Fulgent Genetics Market Cap
Fulgent Genetics has a market cap or net worth of $597.89 million as of July 2, 2024. Its market cap has decreased by -45.65% in one year.
Market Cap
597.89M
Enterprise Value
292.61M
1-Year Change
-45.65%
Ranking
Category
Stock Price
$19.98
Market Cap Chart
Since September 29, 2016, Fulgent Genetics's market cap has increased from $156.50M to $597.89M, an increase of 282.04%. That is a compound annual growth rate of 18.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 599.70M | -30.00% |
| Dec 29, 2023 | 856.70M | -2.28% |
| Dec 30, 2022 | 876.70M | -70.78% |
| Dec 31, 2021 | 3.00B | 137.27% |
| Dec 31, 2020 | 1.26B | 423.90% |
| Dec 31, 2019 | 241.40M | 321.29% |
| Dec 31, 2018 | 57.30M | -26.63% |
| Dec 29, 2017 | 78.10M | -61.81% |
| Dec 30, 2016 | 204.50M | 30.67% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Travere Therapeutics | 610.17M |
| Humacyte | 609.71M |
| Mineralys Therapeutics | 609.68M |
| Phathom Pharmaceuticals | 601.16M |
| Clover Health Investments | 600.69M |
| Zymeworks | 598.87M |
| Surmodics | 598.55M |
| Varex Imaging | 593.05M |